Norsa Pharma
PrivateLast Round
Grant
Apr 16, 2018
Total Funding Raised
$500,000
Company Overview
Norsa Pharma is a Polish pharmaceutical and nutraceutical company that develops and manufactures specialized dietary supplements and medical nutrition products for patients with metabolic, autoimmune, and other specific health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Norsa Pharma Comparables
Compare Norsa Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seeking Health | 72% | |
| Nestlé | 72% | |
| Pharma Nord | 69% |
Norsa Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2018 |
Norsa Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Regional Development Fund | Grant |
| Meta Ventures | Seed |
| Aper Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 177% MoM, reaching 56.1K.
- Nov 11, 2024
Monthly visitors grew 68% MoM to 33.6K.
Norsa Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Norsa Pharma's valuation, stock price, and market status.
Is Norsa Pharma a public or private company?
Norsa Pharma is a private company.
What is the current stock price of Norsa Pharma?
Norsa Pharma is a private company with no public stock price. Caplight tracks Norsa Pharma's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Norsa Pharma worth (valuation)?
Valuation information for Norsa Pharma is not publicly available.
Can I buy Norsa Pharma stock?
Norsa Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Norsa Pharma's last funding round?
Norsa Pharma's most recent funding round was Grant on April 16, 2018.
Who are the main investors in Norsa Pharma?
Key investors in Norsa Pharma include European Regional Development Fund, Meta Ventures, Aper Ventures.
Will Norsa Pharma IPO soon?
No public IPO plans have been announced for Norsa Pharma.
How can I track Norsa Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Norsa Pharma's secondary market activity and sign up for updates.